TrialNature communications2024

Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer.

Wolfgang Beckabir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.